AI in Health Care: Balancing Benefits and Barriers
AI can help alleviate the burden on clinical labs—but only with sufficient investment, enthusiasm, and understanding
AI can help alleviate the burden on clinical labs—but only with sufficient investment, enthusiasm, and understanding
Researchers report the first-ever routine clinical use of an AI-based tool for breast cancer biopsies in a pathology lab.
Experts share new strategies for dealing with hemolysis, icterus, and lipemia interference.
In a new practice guideline, the group also “strongly recommends” that NIPS be offered to patients to screen for fetal SCA.
Circulating tumor DNA sequencing technologies are tackling the challenges of early cancer detection.
Researchers have identified 35 genes found in high expression in people with long-term Lyme disease, which could lead to earlier detection.
Recent study shows scores capable of assessing genetic risk of coronary artery disease can also ID those at high risk of death.
A recent study shows pharmacogenetic testing can help caregivers make better decisions when prescribing antidepressants.
The new CAP guidance addresses use of immune checkpoint inhibitors for evaluating and treating patients with specific cancers.
What the equity rule is, who it affects, and how to comply.
A recent study shows that most patients who underwent such screening were diagnosed at an earlier stage than those who did not.